September 2026
The global nuclear medicine market size was exhibited at USD 14.72 billion in 2026 and is expected to hit around USD 38.39 billion by 2035 with a noteworthy CAGR of 11.26%.
September 2026
The nuclear medicine software market size reached USD 1,069.01 million in 2026, with leading nuclear medicine software market companies including GE Healthcare, Siemens Healthineer.
September 2026
The global nuclear medicine equipment market size is estimated to hit around USD 10.00 billion by 2035 increasing from USD 7.57 billion in 2026, with a CAGR of 3.14%.
September 2026
The global non-oncology precision medicine market size is calculated at USD 101.25 billion in 2026 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
September 2026
The AI in telemedicine market was worth USD 32.30 billion in 2026, with key AI in telemedicine market players including IBM Corporation, Microsoft Corporation.
September 2026
The global geriatric medicines market size is expected to increase from USD 195.36 billion in 2026 to hit around USD 348.40 billion by 2035, with a CAGR of 7.50%.
September 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 350.42 billion in 2026 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
September 2026
The global personalized medicine market was estimated at USD 702.52 billion in 2026 and is expected to hit around USD 1397.63 billion by 2035, at a CAGR of 7.88%%.
September 2026
The global nanomedicine market size was calculated at USD 260.79 billion in 2026 and is projected to hit around USD 687.64 billion by 2035 with a CAGR of 11.4%.
September 2026
The global concierge medicine market size is expected to increase from USD 23.23 billion in 2026 and is projected to hit around USD 41.37 billion by 2035 with a CAGR of 6.63%.
September 2026
The global telemedicine market size is anticipated at USD 188.93 billion in 2026 and is hit around USD 806.89 billion by 2035, expanding at a CAGR of 17.55%.
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The U.S. concierge medicine market generated USD 6.99 billion in 2026, with prominent U.S. concierge medicine market companies including Priority Physicians, Inc., Castle Connolly Private Health Partners, PartnerMD, Concierge Consultants and CardiologyÂ
September 2026
The global nuclear waste management market size is expected to attain around USD 5.87 billion by 2034 increasing from USD 5.13 billion in 2026, with a CAGR of 1.72%.
September 2026
The regenerative medicine market size is valued at USD 53.65 billion in 2026 and is expected to hit around USD 234.85 billion by 2035, growing at a CAGR of 18.29%.
September 2026
The global nuclear reactor market size was valued at USD 31,51 billion in 2026 and is predicted to surge around USD 50.37 billion by 2034, with a CAGR of 6.04%.
September 2026
The global nuclear magnetic resonance spectroscopy market size is projected to hit around USD 2.87 billion by 2035 from USD 1.77 billion in 2026, with a CAGR of 5.50%.
September 2026
The small nuclear reactor market reached USD 8.16 billion in 2026, featuring leading small nuclear reactor market companies such as Deutsche Post DHL Group, United Parcel Service (UPS), FedEx Corporation, Kuehne + Nagel, DB Schenker.
September 2026
The preventive medicine market size reached USD 420.00 billion in 2025, with leading preventive medicine market companies including Pfizer Inc., GlaxoSmithKline plc (GSK), Merck & Co., Inc., Sanofi S.A.
September 2026
The computational medicine and drug discovery software market size reached USD 12.94 billion in 2026, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
September 2026
The U.S. regenerative medicine market was worth USD 24.10 billion in 2026, with key U.S. regenerative medicine market players including Integra LifeSciences Corporation (U.S.), Bristol-Myers Squibb Company (U.S.), American CryoStem Corporation (U.S.).
September 2026
The U.S. personalized medicine market generated USD 207.15 billion in 2026, with prominent U.S. personalized medicine market companies including Thermo Fisher Scientific, Illumina, Johnson and Johnson.
September 2026
The global precision medicine market size is expected to increase from USD 138.67 billion in 2026 and is expected to hit around USD 537.17 billion by 2035, with a CAGR of 16.26%.
August 2026
The global sports medicine market size was evaluated at USD 6.40 billion in 2025 and is expected to attain around USD 13.97 billion by 2035 with a CAGR of 8.12%.
August 2026
The global veterinary medicine market size was valued at USD 56.68 billion in 2025 and is expected to worth around USD 115.15 billion by 2035 with a CAGR of 7.35%.
July 2026
The global aesthetic medicine market size accounted for USD 100.47 billion in 2025 and is expected to hit around USD 252.63 billion by 2035 at a CAGR of 9.66%.
July 2026
The nuclear fusion and fission reactor market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,611.83 million 2035 increasing from USD 982.20 million in 2026, with a CAGR of 18.80%.
June 2026
The global nuclear fusion market size is expected to be worth around USD 843.46 billion by 2040 and it is growing at a healthy CAGR 6% during the forecast period from 2030 to 2040.
June 2026
The global regenerative medicine in dermatology market is poised to grow as advanced cell-based and biomaterial therapies revolutionize skin repair and restoration.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com